/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mark G. Wise

American Veterinary Medical Association(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

80

Papers

2.9K

Citations

29

h-index

35

i10-index

Mark G. Wise is an academic researcher from American Veterinary Medical Association. The author has contributed to research in topics: Antibiotic Resistance in Bacteria & Antibiotic Use and Resistance & Antibiotics Pharmacokinetics and Efficacy. The author has an h-index of 29, co-authored 68 publications.

ORCID: 0000-0001-7356-1851

Research Topics

Antibiotic Resistance in Bacteria Antibiotic Use and Resistance Antibiotics Pharmacokinetics and Efficacy Bacterial Identification and Susceptibility Testing Pneumonia and Respiratory Infections

Papers by this author

works

In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)

2018 · International Journal of Antimicrobial Agents · 188 citations

https://doi.org/10.1016/j.ijantimicag.2018.10.007

Krystyna M. Kazmierczak Masakatsu Tsuji Mark G. Wise Meredith Hackel

Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program

2015 · Antimicrobial Agents and Chemotherapy · 90 citations

https://doi.org/10.1128/aac.01870-15

Patricia A. Bradford Krystyna M. Kazmierczak Douglas J. Biedenbach Mark G. Wise

Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022

2024 · Journal of Global Antimicrobial Resistance · 67 citations

https://doi.org/10.1016/j.jgar.2024.03.020

Mark G. Wise James A. Karlowsky Naglaa Mohamed Elizabeth D. Hermsen

Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in <i>Pseudomonas aeruginosa</i> isolates collected globally: results from ATLAS 2017–2019

2023 · Journal of Antimicrobial Chemotherapy · 33 citations

https://doi.org/10.1093/jac/dkad127

Ana Cristina Gales Gregory G. Stone Daniel F. Sahm Mark G. Wise

In vitro activity of aztreonam–avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019–2021

2023 · European Journal of Clinical Microbiology & Infectious Diseases · 33 citations

https://doi.org/10.1007/s10096-023-04645-2

Mark G. Wise James A. Karlowsky Naglaa Mohamed Shweta Kamat

In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–2021

2023 · Journal of Global Antimicrobial Resistance · 6 citations

https://doi.org/10.1016/j.jgar.2023.08.022

Mark G. Wise James A. Karlowsky Meredith Hackel Mohamed Amine Harti

Research topics

topics

Antibiotic Resistance in Bacteria

Antibiotic Use and Resistance

Antibiotics Pharmacokinetics and Efficacy

Bacterial Identification and Susceptibility Testing

Pneumonia and Respiratory Infections

Chat about Author

Papers

Chat

Click to start Chat